|
|
|
|
| LEADER |
01261nmm a2200265 u 4500 |
| 001 |
EB000625958 |
| 003 |
EBX01000000000000000479040 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9781461551959
|
| 100 |
1 |
|
|a Gasparini, Giampietro
|e [editor]
|
| 245 |
0 |
0 |
|a Prognostic variables in node-negative and node-positive breast cancer
|h Elektronische Ressource
|c edited by Giampietro Gasparini
|
| 250 |
|
|
|a 1st ed. 1998
|
| 260 |
|
|
|a New York, NY
|b Springer US
|c 1998, 1998
|
| 300 |
|
|
|a VI, 428 p
|b online resource
|
| 505 |
0 |
|
|a Accepted utilities and novel prospects --
|
| 505 |
0 |
|
|a new ligands and receptors and their role in breast cancer -- c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients -- HER-2/neu as a predictive marker of response to breast cancer therapy --
|
| 505 |
0 |
|
|a When is “statistically significant” clinically useful? -- Prognostic variables in node-negative and node-positive breast cancer — editorial -- Author index
|
| 653 |
|
|
|a Oncology
|
| 653 |
|
|
|a Oncology
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4615-5195-9?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.994
|